ELV · Elevance Health, Inc. · Earnings Call Transcripts & Audio
$388.82
-3.91 (-1.00%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$85.90B
Shares
216.87M
Volume · Sep 30
1.3M
Avg daily vol (3M)
1.24M
Elevance Health, Inc. Earnings Call Transcripts
Quarterly earnings calls for Elevance Health, Inc. (ELV), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲11.5%
$39.94B
$1.60B
'22 Q3
22-10-19
▲9.2%
$39.93B
$865.00M
'22 Q4
23-01-25
▲10.7%
$42.17B
$1.99B
'23 Q1
23-04-19
▲13%
$43.67B
$1.85B
'23 Q2
23-07-19
▲7.3%
$42.85B
$1.29B
'23 Q3
23-10-18
▲6.8%
$42.65B
$856.00M
'23 Q4
24-01-24
▲1%
$42.58B
$2.25B
'24 Q1
24-04-18
▲0.5%
$43.89B
$2.30B
'24 Q2
24-07-17
▲5.3%
$45.11B
$1.02B
'24 Q3
24-10-17
▲6.6%
$45.44B
$418.00M
'24 Q4
25-01-23
▲14.8%
$48.89B
$2.18B
'25 Q1
25-04-22
▲13.4%
$49.78B
$1.74B
'25 Q2
25-07-17
▲12.4%
$50.71B
$1.19B
'25 Q3
25-10-21
▲9.5%
$49.75B
$547.00M
'25 Q4
26-01-28
▲2.6%
$50.18B
$1.76B
'26 Q1
26-04-22
LATEST
▲1.4%
$50.47B
$1.46B
'26 Q2
26-07-15
Conference
Investor event
2026-09-10
Elevance Health, Inc. (ELV) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-15
Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript
Confident tone
Medicaid Discipline and Market Exits
Raised EPS Guidance and 2027 Growth Outlook
Individual ACA Business
Revenue
$50.47B
▲ 1.4% YoY Diluted EPS
$6.71
▼ 13.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-04-22
Elevance Health, Inc. (ELV) Q1 2026 Earnings Call Transcript
Confident tone
Medicaid Cost Trend and Behavioral Health Actions
Medicare Advantage Repositioning and 2027 Bid Environment
CMS Risk Adjustment Notice
Revenue
$50.18B
▲ 2.6% YoY Diluted EPS
$8.00
▼ 16.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-01-28
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Balanced tone
Affordability and cost trend
Carillon and operational execution
EPS guidance and long-term growth target
Revenue
$49.75B*
▲ 9.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-21
Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript
Cautious tone
Medicaid margin pressure and acuity
2026 planning posture and EPS guidance
Carelon growth and integration
Revenue
$50.71B
▲ 12.4% YoY Diluted EPS
$5.32
▲ 22% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-17
Elevance Health, Inc. (ELV) Q2 2025 Earnings Call Transcript
Cautious tone
ACA Marketplace morbidity and pricing
Medicaid rate alignment and membership
Carelon services and Carelon Rx growth
Revenue
$49.78B
▲ 13.4% YoY Diluted EPS
$7.72
▼ 21.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-22
Elevance Health, Inc. (ELV) Q1 2025 Earnings Call Transcript
Positive tone
Carelon Growth & External Payer Relationships
Membership Growth & Retention
Medicaid Rate Alignment & July Renewals
Revenue
$48.89B
▲ 14.8% YoY Diluted EPS
$9.61
▲ 0.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-01-23
Elevance Health, Inc. (ELV) Q4 2024 Earnings Call Transcript
Positive tone
Carelon services expansion
Medicare Advantage growth and strategy
Medicaid cost trends and rate sufficiency
Revenue
$45.44B*
▲ 6.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-17
Elevance Health, Inc. (ELV) Q3 2024 Earnings Call Transcript
Balanced tone
Medicaid acuity-rate mismatch and elevated medical costs
Carelon growth and acquisitions
State partnership and rate recovery over time
Revenue
$45.11B
▲ 5.3% YoY Diluted EPS
$4.36
▼ 20% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-17
Elevance Health, Inc. (ELV) Q2 2024 Earnings Call Transcript
Confident tone
CarelonRx investment and integration
Medicare Advantage bids and Star ratings
Carelon Services growth
Revenue
$43.89B
▲ 0.5% YoY Diluted EPS
$9.85
▲ 26.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-18
Elevance Health, Inc. (ELV) Q1 2024 Earnings Call Transcript
Positive tone
Value-Based Care Partnership with CD&R
Medicare Advantage and Star Ratings
Carelon Growth
Revenue
$42.58B
▲ 1% YoY Diluted EPS
$9.59
▲ 15.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-01-24
Elevance Health, Inc. (ELV) Q4 2023 Earnings Call Transcript
Confident tone
Carelon Growth and Strategy
Stars and Quality Ratings
Medicare Advantage
Revenue
$42.65B*
▲ 6.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-18
Elevance Health, Inc. (ELV) Q3 2023 Earnings Call Transcript
Revenue
$42.85B
▲ 7.3% YoY Diluted EPS
$5.45
▼ 17.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-19
Elevance Health, Inc. (ELV) Q2 2023 Earnings Call Transcript
Revenue
$43.67B
▲ 13% YoY Diluted EPS
$7.79
▲ 15.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-19
Elevance Health, Inc. (ELV) Q1 2023 Earnings Call Transcript
Revenue
$42.17B
▲ 10.7% YoY Diluted EPS
$8.30
▲ 13.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-25
Elevance Health, Inc. (ELV) Q4 2022 Earnings Call Transcript
Revenue
$39.93B*
▲ 9.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-19
Elevance Health, Inc. (ELV) Q3 2022 Earnings Call Transcript
Revenue
$39.94B
▲ 11.5% YoY Diluted EPS
$6.62
▲ 8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-20
Elevance Health, Inc. (ELV) Q2 2022 Earnings Call Transcript
Revenue
$38.63B
▲ 14.1% YoY Diluted EPS
$6.73
▼ 7.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-20
Elevance Health, Inc. (ELV) Q1 2022 Earnings Call Transcript
Revenue
$38.09B
▲ 17.6% YoY Diluted EPS
$7.32
▲ 9.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-01-26
Elevance Health, Inc. (ELV) Q4 2021 Earnings Call Transcript
Revenue
$36.58B*
▲ 14.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-20
Elevance Health, Inc. (ELV) Q3 2021 Earnings Call Transcript
Revenue
$35.82B
▲ 15% YoY Diluted EPS
$6.13
▲ 604.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-21
Elevance Health, Inc. (ELV) Q2 2021 Earnings Call Transcript
Revenue
$33.85B
▲ 15.7% YoY Diluted EPS
$7.25
▼ 18.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-21
Elevance Health, Inc. (ELV) Q1 2021 Earnings Call Transcript
Revenue
$32.38B
▲ 9.3% YoY Diluted EPS
$6.71
▲ 13% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-27
Elevance Health, Inc. (ELV) Q4 2020 Earnings Call Transcript
Revenue
$31.82B
▲ 16.1% YoY Diluted EPS
$2.19
▼ 39.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-28
Elevance Health, Inc. (ELV) Q3 2020 Earnings Call Transcript
Revenue
$31.16B
▲ 16.8% YoY Diluted EPS
$0.87
▼ 80.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-29
Elevance Health, Inc. (ELV) Q2 2020 Earnings Call Transcript
Revenue
$29.26B
▲ 14.9% YoY Diluted EPS
$8.91
▲ 104.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
Elevance Health, Inc. (ELV) Q1 2020 Earnings Call Transcript
Revenue
$29.62B
▲ 20.1% YoY Diluted EPS
$5.94
▲ 0.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-01-29
Elevance Health, Inc. (ELV) Q4 2019 Earnings Call
Revenue
$27.41B
▲ 17.3% YoY Diluted EPS
$3.62
▲ 124.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 earnings calls
Key facts
CIK
1156039
CUSIP
036752103
13F (30d)
53 filings
21 filers
Visit website
Investor relations